• Explore /
  • Poster
  • / Safety and efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of patients with advanced unresectable hepatocellular carcinoma.

Safety and efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of patients with advanced unresectable hepatocellular carcinoma.

Abstract Poster

Authors

null

Jinpeng Li

Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

Jinpeng Li , Yuntao Jia , Huihui Han , Yanyan Lin , Jinlong Song

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

ChiCTR2000039508

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4079)

DOI

10.1200/JCO.2023.41.16_suppl.4079

Abstract #

4079

Poster Bd #

400

Abstract Disclosures

Similar Posters

First Author: Claudia A.M. Fulgenzi

First Author: Xiaoyun Zhang

First Author: Xiaodong Wang

First Author: Zhibo Zhang